Last Updated: 1/28/21
COVID-19 Vaccines and People with HIV: Frequently Asked Questions – HIV Medicine Association
EACS & BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH) – May 25, 2020
Children’s HIV Association (CHIVA) statement on COVID-19 and HIV – May 5, 2020
COVID-19: Special Considerations for People Living with HIV – IDSA and HIVMA, April 17, 2020
What does COVID-19 mean for people living with HIV: online information – HIV i-Base, March 27, 2020
Journal Articles
Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection – Sara Madge et al, Sexually Transmitted Infections, September 2, 2020
COVID-19 in people with HIV – Zhe Xu, Chao Zhang and Fu-Sheng Wang, Lancet HIV, May 28, 2020
People Who Use Drugs and Drug Service Providers
Harm Reduction
Coronavirus and drug harm reduction – Transform Drug Policy Foundation
Resources for drug use and COVID-19 risk reduction – Vital Strategies
Correctional and Detention Facilities
COVID-19 Guidance for Correctional and Detention Facilities – CDC
Tracking Public Investment in Global COVID-19 R&D – UAEM, SNMA, AMSA
COVID-19 Research Registry – American Society for Microbiology
Ongoing Studies for the Treatment and Prevention of the COVID-19 Virus – AVAC
COVID-19 Vaccine and Therapeutics Tracker – BioRender
COVID-19 Treatment and Vaccine Tracker – Milken Institute
STAT News COVID-19 Drugs and Vaccines Tracker
COVID-19 Clinical Trials Explorer – Jesse Burk Rafel, MD, MRes and Marina Marin, MS
Coronavirus Treatment and Prevention with Monoclonal Antibodies – JAMA Network (video)
COVID-19 Diagnostics In Context – Center for Systems Biology, Massachusetts General Hospital
SARS-CoV-2 Diagnostic Pipeline – FIND
SARS-CoV-2 Molecular Assay Evaluation: Results
Emergency Use Authorized Serology Test Performance – US Food and Drug Administration
IDSA COVID-19 Antibody Testing Primer
Illustrated diagnostics glossary (pp.56-69) – Treatment Action Group
Emergency Use Authorization for Vaccines Explained – U.S. Food and Drug Administration (FDA)
UNICEF: COVID-19 Vaccine Market Dashboard
Advocates Guide to COVID-19 Vaccine Access
DRAFT landscape of COVID-19 candidate vaccines – World Health Organization
Coronavirus Vaccine Tracker – New York Times
COVID-19 Vaccine Tracker – Jeff Craven, Regulatory Focus
VAXMAP: An open source-based map of COVID-19 candidate vaccines and manufacturing capacity
Making a vaccine accessible: A glossary of terms – Devex
SARS-CoV-2 vaccines in development – Florian Krammer, Nature, September 23, 2020
Rapid COVID-19 vaccine development – Barney S. Graham, Science, May 8, 2020
The race for coronavirus vaccines: a graphical guide – Ewen Callaway, Nature, April 28, 2020
Cheat Sheet: COVID-19 Vaccine Pipeline – AVAC, August 2020
Advocates’ Guide: The risks and benefits of expedited COVID-19 vaccine research – AVAC, August 2020
Developing Covid-19 Vaccines at Pandemic Speed – Nicole Lurie et al, NEJM, March 30, 2020
Coronavirus vaccines: five key questions as trials begin – Ewen Callaway, Nature, March 18, 2020
Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees – Shibo Jiang, Nature, March 16, 2020
COVID Advocates Advisory Board
Good Participatory Practice (GPP) Guidelines – AVAC
Good Participatory Practice for COVID-19 clinical trials: a toolbox – World Health Organization
Engage: Global Connections to Build Capacity – AVAC
Toolbox for Conducting Community-Engaged Research – The Scripps Institute
Community-Engaged Research – UCSF